COMPARISON OF DYSPROSIUM DTPA BMA AND SUPERPARAMAGNETIC IRON-OXIDE PARTICLES AS SUSCEPTIBILITY CONTRAST AGENTS FOR PERFUSION IMAGING OF REGIONAL CEREBRAL-ISCHEMIA IN THE RAT
O. Haraldseth et al., COMPARISON OF DYSPROSIUM DTPA BMA AND SUPERPARAMAGNETIC IRON-OXIDE PARTICLES AS SUSCEPTIBILITY CONTRAST AGENTS FOR PERFUSION IMAGING OF REGIONAL CEREBRAL-ISCHEMIA IN THE RAT, Journal of magnetic resonance imaging, 6(5), 1996, pp. 714-717
The aim of the study was to compare the first-passage profiles of dysp
rosium diethylenetriamine penta-acetic acid bis(methylamide) (DTPA BMA
) and the superparamagnetic iron oxide particles NSR 0430 in regions w
ith severe and moderate cerebral ischemia, In seven rats subjected to
middle cerebral artery occlusion, two dynamic MR perfusion imaging ser
ies were acquired after intravenous bolus injections of .5 mmol/kg dys
prosium DTPA BMA and .06 mmolFe/kg iron oxide particles, respectively,
The doses were chosen to obtain similar maximum signal change in norm
ally perfused brain. The first-passage profiles were compared in a reg
ion of interest (ROI) in the core area with severe ischemia and in a R
OI in the penumbra area of moderate ischemia. The results were compare
d both as the calculated mean signal intensity versus time curves for
all seven rats and statistically for an estimated mean transit time (M
TT) after gamma variate fitting of the calculated concentration versus
time curves. The first-passage profiles for the two contrast agents w
ere similar, both in the core area of severe ischemia and in the penum
bra area of moderate ischemia. In this rat stroke model, dysprosium DT
PA BMA and the superparamagnetic iron oxide particles NSR 0430 were fo
und to be equally efficacious for the diagnosis of the perfusion defic
it, but if safe for human investigations, iron oxide particles would h
ave an advantage as equal susceptibility effect may be achieved with s
maller injection volumes.